If you live with Type 1 diabetes — or love someone who does — you know the story:
One day, your immune system decides your pancreas is public enemy number one. Insulin production crashes, and life becomes a 24/7 balancing act of blood sugar levels, carb counting, and constant management. For years, the narrative around Type 1 was grim: once it starts, there’s no stopping it.
No “pause” button. No “let’s slow this down” option.
Until now.
Enter Tzield — the first and only treatment that can delay the onset of clinical Type 1 diabetes in at-risk individuals
Not cure it. Not erase it.
But delay it. Sometimes by years.
And if you think that doesn’t sound like a big deal — imagine getting a few more birthdays, summer breaks, college years, without insulin shots, CGMs, or late-night blood sugar crashes.
For some families, that’s life-changing.
So… what even is Tzield?
Tzield (or teplizumab-mzwv if you want to win at Scrabble) is an immunotherapy. It works by calming down the immune system before it fully attacks the pancreas. It’s given as a once-daily infusion over 14 days.
And while it’s not for everyone — it’s designed for people very early in the Type 1 process — it represents a massive shift: From only treating diabetes after it happens, to preventing it for as long as possible.
Here’s the fun (and slightly frustrating) part
Tzield has been approved by the FDA. It’s making waves at conferences. Endocrinologists are thrilled. But — like many medical breakthroughs — it’s not exactly sitting on the shelf at every corner pharmacy. In fact, in much of the region?
You can’t get it easily.
Except… at the metabolic pharmacy.
(Yep. That’s us.)
We pride ourselves on bringing the most advanced diabetes care tools, medications, and solutions to our community — often long before they become “standard” elsewhere.
Tzield is just one example.
TLDR:
Tzield delays the full onset of Type 1 diabetes
It’s a 14-day infusion that can buy people years of pancreas function
It’s groundbreaking — and extremely hard to find
But metabolic Pharmacy stocks it, right here, right now